Weill Cornell Medicine
New York, NY
Dr. Fabiana Gregucci earned her Doctor of Medicine and Surgery, Masters in Biostatistics, and completed her residency in Radiation Oncology from the University of Padua, Italy.
After completing her training, Dr. Gregucci worked as a Radiation Oncologist at Istituto Oncologico Veneto, Padova and Ospedale Sacro Cuore Don Calabria, Negrar – Verona (Italy). Subsequently, she joined Regional General Hospital F. Miulli - Bari (Italy), where she has been engaged in both clinical and research activities. Dr. Gregucci is an expert in breast cancer, central nervous system cancer, pancreatic cancer, and stereotactic radiotherapy. She is an executive board member of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) study group for Breast Cancer and Central Nervous System. In 2017 She was awarded an AIRO Scholarship for an international training project and completed the training program on Radiomics Research at MD Anderson Cancer Center (Texas, USA). Also, she is co-investigator of "Implementation of the data collection in a National Register to ensure the health of the breast cancer patient and the transferability of know-how" and the "Linac Based STereotactic Arrhythmia Radioablation (STAR) of Atrial Fibrillation" study (NCT04575662). In 2022, she was acknowledged by the Italian Ministry of Education, University, Research as a University Professor. In 2022 he joined Weill Cornell Medicine as Fellow and in 2023 she was appointed as Associate Researcher.
Disclosures:
Monday, September 30, 2024
3:00 PM – 4:00 PM ET
Monday, September 30, 2024
3:00 PM – 4:00 PM ET
2682 - Dosimetric and Clinical Data from Linac-Based Stereotactic Arrhythmia Radioablation
Monday, September 30, 2024
3:00 PM – 4:00 PM ET